DUBLIN--(BUSINESS WIRE)--The "DNA Sequencing Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period (2020 to 2025).
Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and growing investment in R&D.
Companies Mentioned
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation (Beckman Coulter Inc.)
- Eurofins Scientific
- F. Hoffmann-La Roche
- Illumina, Inc.
- Merck KGaA
- Pacific Biosciences of California Inc.
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
Key Market Trends
Next Generation Sequencing is Expected to Show Lucrative Growth Opportunity in the Platform Segment
Next-generation Sequencing can be of several types based on the technology. For example, the benefits offered by whole genome sequencing techniques, such as ease of handling, affordability, and accuracy, are expected to boost their demand. Additionally, these tests are usually preferred by the market players as a single test, which is capable of providing information on multiple factors, such as virulence, serotype, and resistance. FDA is applying NGS in innovative ways, which can help reduce foodborne illnesses and deaths. Isolation of pathogens from food or environmental samples may be compared to clinical isolates from patients. A reliable link between the two is made, which helps define the scope of a foodborne illness outbreak. Owing to such factors, the concerned segment is expected to observe a steady growth over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America dominated the global market studied, in 2018, owing to the increase in funding and support activities by the government and non-government entities, especially in the United States. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute) have supported the work on sequencing of the human genome, and fund research on the genome's structure, function, and role in health and disease. They also support studies on the ethical, legal, and social implications (ELSI) of genome research. The US National Human Genome Research Institute and the US National Academy of Medicine organized 90 leaders in genomic medicine from the United States and 25 other countries in Genomic Medicine Symposium in 2014, in order to identify opportunities for collaborations that promote the responsible practice of genomic medicine.
Key Topics Covered:
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Technological Advancements in DNA Sequencing
4.2.2 Increasing Application in Clinical Diagnosis and Drug Discovery
4.2.3 Growing Investment in R&D
4.3 Market Restraints
4.3.1 Interpretation of Complex Data and Lack of Skilled Professionals
4.3.2 Legal and Ethical Issues
4.4 Porter's Five Force Analysis
5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Instruments
5.1.2 Consumables (Kits, Reagents)
5.1.3 Others
5.2 Platform
5.2.1 Sanger
5.2.2 Next Generation Sequencing
5.2.3 qPCR
5.2.4 Others
5.3 Application
5.3.1 Diagnostics
5.3.2 Personalized Medicine
5.3.3 Others (Biomarkers, Forensics, Reproductive Health, etc.)
5.4 End User
5.4.1 Hospitals and Healthcare Organizations
5.4.2 Academics and Research Institutions
5.4.3 Pharmaceutical and Biotechnology Companies
5.4.4 Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Bio-Rad Laboratories Inc.
6.1.3 Danaher Corporation (Beckman Coulter Inc.)
6.1.4 Eurofins Scientific
6.1.5 F. Hoffmann-La Roche
6.1.6 Illumina, Inc.
6.1.7 Merck KGaA
6.1.8 Pacific Biosciences of California Inc.
6.1.9 PerkinElmer Inc.
6.1.10 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/hwotcu
